arrow_back Back to App

May 2022: National Brain Tumor Awareness Month in the USA

The U.S. Senate designated May 2022 as National Brain Tumor Awareness Month. This aims to increase public understanding of brain tumors, support affected individuals, and encourage further research into new treatments. The initiative highlights the challenges of brain tumors and the need for improved medical solutions.
Key points
Designation of May 2022 as National Brain Tumor Awareness Month in the USA.
Increased public awareness of brain tumors and their impact on lives.
Support for patients, families, and caregivers, and encouragement for new treatment research.
article Official text account_balance Process page
Adopted
Citizen Poll
No votes cast
Additional Information
Print number: 117_SRES_648
Sponsor: Sen. Daines, Steve [R-MT]
Process start date: 2022-05-24
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

A resolution designating May 2022 as "National Brain Tumor Awareness Month".

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_SRES_648.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2022-05-24.

What are the main provisions?

Key points include:

  • Designation of May 2022 as National Brain Tumor Awareness Month in the USA.
  • Increased public awareness of brain tumors and their impact on lives.
  • Support for patients, families, and caregivers, and encouragement for new treatment research.
What is the specific legal status?

The current status is Adopted.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Daines, Steve [R-MT].

What is the latest detailed status?

The latest detailed status is: Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S2669; text: CR S2667-2668)

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-29.

CATEGORIES

Health